Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Oct;5(4):516-27.
doi: 10.1016/j.nurt.2008.08.002.

ALS drug development: reflections from the past and a way forward

Affiliations
Review

ALS drug development: reflections from the past and a way forward

Swati Aggarwal et al. Neurotherapeutics. 2008 Oct.

Abstract

Tremendous advances in our understanding of pathogenesis of amyotrophic lateral sclerosis (ALS) have provided a rich pipeline of drugs for clinical trialists. At least 32 unique compounds have been tested. Nevertheless, riluzole is currently the only treatment that prolongs survival. We present a critical overview of past clinical trials, how therapies are selected for testing in people, challenges with ALS clinical trial design and conduct, and ways to best move forward.

PubMed Disclaimer

References

    1. Charcot J, Joffroy A. Deux cas d’atrophie musculaire progressive. Arch Physiol. 1869;2:354–367.
    1. Phukan J, Pender NP, Hardiman O. Cognitive impairment in amyotrophic lateral sclerosis. Lancet Neurol. 2007;6:994–1003. doi: 10.1016/S1474-4422(07)70265-X. - DOI - PubMed
    1. Hammad M, Silva A, Glass J, Sladky JT, Benatar M. Clinical, electrophysiologic, and pathologic evidence for sensory abnormalities in ALS. Neurology. 2007;69:2236–2242. doi: 10.1212/01.wnl.0000286948.99150.16. - DOI - PubMed
    1. Mitsumoto H, Chad D, Pioro E. Amyotrophic lateral sclerosis. New York: Oxford Press; 1998.
    1. McGuire V, Longstreth W, Koepsell T, van Belle G. Incidence of amyotrophic lateral sclerosis in three counties in western Washington state. Neurology. 1996;47:571–573. doi: 10.1212/WNL.47.2.571. - DOI - PubMed

MeSH terms